drugset
drugset / Trial / NCT03909763

Combination of Danazole With Berberine in the Treatment of ITP

NCT03909763 ↗

Phase 2 Unknown 55 enrolled Peking University People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

A prospective, multicenter, open-label, Phase II, single arm, trial performed in 6 departments of hematology in China

Timeline

Start
2016-01-20
Primary completion
2020-12-30
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Berberine Traditional medicine (herbal / TCM) 0.3 g Oral
Subject Danazol Other / unclassified 200 mg Oral

Indications

No indication recorded.